Home

Firefly Neuroscience, Inc. - Common Stock (AIFF)

3.6500
+0.1000 (2.82%)

Firefly Neuroscience, Inc. is a pioneering company focused on developing innovative neurotechnology solutions aimed at enhancing the understanding and treatment of neurological conditions

The firm leverages advanced research and cutting-edge technology to create tools and therapies that enable more precise diagnosis and effective management of brain-related disorders. Through its commitment to scientific excellence and patient-centered approaches, Firefly strives to revolutionize the field of neuroscience, ultimately improving the quality of life for individuals affected by neurological diseases.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close3.550
Open3.650
Bid3.550
Ask3.750
Day's Range3.650 - 3.740
52 Week Range1.860 - 9.000
Volume9,014
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume7,271,297

News & Press Releases

Innovative Stocks to Watch: PNPN.V, NMHI, PRSO, AIFF Leading Bold Industry Transformations – More Stocks Inside!
Discover the latest breakthroughs and strategic moves from industry-leading companies driving change across technology, healthcare, agriculture, and sustainability. From Nature's Miracle's game-changing investment deal to Power Nickel's high-potential mineral exploration, these organizations are setting the stage for innovation and growth in 2025.
Via AB Newswire · January 14, 2025
Dow Gains Over 200 Points; Signet Jewelers Shares Plungebenzinga.com
Via Benzinga · January 14, 2025
Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higherbenzinga.com
Via Benzinga · January 14, 2025
What's Going On With Firefly Neuroscience Stock Tuesday?benzinga.com
Firefly Neuroscience shares are trading higher on Tuesday after the company announced the advancement of research to assess a patient's brain age.
Via Benzinga · January 14, 2025
Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In Decemberbenzinga.com
Via Benzinga · January 14, 2025
12 Information Technology Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 30, 2024
12 Information Technology Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 28, 2024
12 Information Technology Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 25, 2024
12 Information Technology Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 22, 2024
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQDRUG), a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, today announced that it is once again collaborating with Firefly Neuroscience, Inc. (Firefly) NASDAQ: AIFFNASDAQAIFF)
By Bright Minds Biosciences · Via GlobeNewswire · October 21, 2024
12 Information Technology Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · October 18, 2024
12 Information Technology Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · October 17, 2024
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysisbenzinga.com
Firefly Neuroscience partners with Bright Minds Biosciences to analyze positive Phase 1 data of BMB-101 using advanced AI technology, setting the stage for Phase 2 trials.
Via Benzinga · October 17, 2024
12 Information Technology Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 17, 2024
12 Information Technology Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 16, 2024